• Uncovering a different type of heart failure

    Heart failure with preserved ejection fraction (HFpEF) affects a significant portion of heart failure patients.

  • Research for neuroblastoma stem cell therapy

    Discovery of functional binding protein for salinomycin could open new research in targeting neuroblastoma stem cells.

  • Progress made in stage III lung cancer

    Several therapies are on the horizon for patients with resectable stage III lung cancer.

Our people are at the forefront of healthcare

Why Baylor Scott & White Health

We’ve created a transformative model for the health care industry that eliminates waste, improves coordination of care and helps us better manage chronic disease.

Medical Education

Baylor Scott & White has both clinical and research campuses for the Texas A&M Health Science Center (HSC) College of Medicine. In addition, we are an accredited provider for the Accreditation Council for Continuing Medical Education (ACCME).

Our Departments

Our extensive network of 51 hospitals and more than 1,000 patient care sites – including specialized centers, institutes and regional clinics – offers your patients a full range of medical expertise.

Innovation with a commitment to every patient

Heart transplantation patients older than 65 with end-stage heart failure

Age has traditionally been a limiting factor for advanced heart failure therapies.

Pediatric Subspecialty for the Primary Care Provider

The purpose of the conference is provide primary care providers with information on the recognition and evaluation of specific pediatric subspecialty disorders.

Colorectal Cancer Study

The purpose of this trial is to study the combination Nab-rapamycin with FOLFOX and Bevacizumab has on advanced metastatic colorectal cancer.